Distillate Capital Partners LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1741001
CHICAGO, IL
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,605,455
+$3,319,251 QoQ
Shares Held
92,592
-0.7% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#125
of 768 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Distillate Capital Partners LLC holds $46,491,118 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (33.6% of the industry book) .
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,605,455 | 92,592 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,286,204 | 93,261 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,124,806 | 92,539 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,254,118 | 94,416 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,285,663 | 121,614 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,354,663 | 129,789 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||